Title |
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
|
---|---|
Published in |
Scientific Reports, October 2017
|
DOI | 10.1038/s41598-017-13282-7 |
Pubmed ID | |
Authors |
Robin L Carhart-Harris, Leor Roseman, Mark Bolstridge, Lysia Demetriou, J Nienke Pannekoek, Matthew B Wall, Mark Tanner, Mendel Kaelen, John McGonigle, Kevin Murphy, Robert Leech, H Valerie Curran, David J Nutt |
Abstract |
Psilocybin with psychological support is showing promise as a treatment model in psychiatry but its therapeutic mechanisms are poorly understood. Here, cerebral blood flow (CBF) and blood oxygen-level dependent (BOLD) resting-state functional connectivity (RSFC) were measured with functional magnetic resonance imaging (fMRI) before and after treatment with psilocybin (serotonin agonist) for treatment-resistant depression (TRD). Quality pre and post treatment fMRI data were collected from 16 of 19 patients. Decreased depressive symptoms were observed in all 19 patients at 1-week post-treatment and 47% met criteria for response at 5 weeks. Whole-brain analyses revealed post-treatment decreases in CBF in the temporal cortex, including the amygdala. Decreased amygdala CBF correlated with reduced depressive symptoms. Focusing on a priori selected circuitry for RSFC analyses, increased RSFC was observed within the default-mode network (DMN) post-treatment. Increased ventromedial prefrontal cortex-bilateral inferior lateral parietal cortex RSFC was predictive of treatment response at 5-weeks, as was decreased parahippocampal-prefrontal cortex RSFC. These data fill an important knowledge gap regarding the post-treatment brain effects of psilocybin, and are the first in depressed patients. The post-treatment brain changes are different to previously observed acute effects of psilocybin and other 'psychedelics' yet were related to clinical outcomes. A 'reset' therapeutic mechanism is proposed. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 101 | 21% |
United Kingdom | 28 | 6% |
Canada | 15 | 3% |
Australia | 7 | 1% |
India | 7 | 1% |
Germany | 6 | 1% |
Iran, Islamic Republic of | 6 | 1% |
Ireland | 5 | 1% |
Chile | 5 | 1% |
Other | 71 | 15% |
Unknown | 232 | 48% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 403 | 83% |
Scientists | 45 | 9% |
Practitioners (doctors, other healthcare professionals) | 26 | 5% |
Science communicators (journalists, bloggers, editors) | 9 | 2% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1414 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 317 | 22% |
Student > Master | 184 | 13% |
Researcher | 140 | 10% |
Student > Ph. D. Student | 116 | 8% |
Other | 71 | 5% |
Other | 157 | 11% |
Unknown | 429 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 213 | 15% |
Psychology | 212 | 15% |
Medicine and Dentistry | 166 | 12% |
Biochemistry, Genetics and Molecular Biology | 86 | 6% |
Agricultural and Biological Sciences | 69 | 5% |
Other | 197 | 14% |
Unknown | 471 | 33% |